Classes
Publications
- Sonidegib potentiates the cancer cells' sensitivity to cytostatic agents by functional inhibition of ABCB1 and ABCG2 in vitro and ex vivo2022 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Dabrafenib inhibits ABCG2 and cytochrome P450 isoenzymes; potential implications for combination anticancer therapy2022 | Faculty of Pharmacy in Hradec Králové
- Isocitrate dehydrogenase 2 inhibitor enasidenib synergizes daunorubicin cytotoxicity by targeting aldo-keto reductase 1C3 and ATP-binding cassette transporters2022 | Faculty of Pharmacy in Hradec Králové
- Roles of CYP3A4, CYP3A5 and CYP2C8 drug-metabolizing enzymes in cellular cytostatic resistance2021 | Faculty of Pharmacy in Hradec Králové
- Buparlisib is a novel inhibitor of daunorubicin reduction mediated by aldo-keto reductase 1C32019 | Faculty of Pharmacy in Hradec Králové
- Inhibition of human anthracycline reductases by emodin - A possible remedy for anthracycline resistance2016 | Faculty of Pharmacy in Hradec Králové
- Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment2015 | Faculty of Pharmacy in Hradec Králové
- Isoquinoline alkaloids as a novel type of AKR1C3 inhibitors2014 | Faculty of Pharmacy in Hradec Králové
- Anthracycline resistance mediated by reductive metabolism in cancer cells: The role of aldo-keto reductase 1C32014 | Faculty of Pharmacy in Hradec Králové
- Purvalanol A, Olomoucine II and Roscovitine Inhibit ABCB1 Transporter and Synergistically Potentiate Cytotoxic Effects of Daunorubicin In Vitro2013 | Faculty of Pharmacy in Hradec Králové
Loading network view...
